Showing results (1811-1820 of 1,851) with videos related to

Sort By:
Pageof 186
Transplantation and Cellular Therapy|July 19, 2022
Characteristics of Graft-Versus-Host Disease (GvHD) After Post-Transplantation Cyclophosphamide Versus Conventional GvHD ProphylaxisRima M Saliba, Amin M Alousi, Joseph Pidala, et al.
JCI Insight|July 22, 2025
Integrating pulmonary and systemic transcriptomes to characterize lung injury after pediatric hematopoietic stem cell transplantEmma M Pearce, Erica Evans, Madeline Y Mayday, et al.
Medrxiv : the Preprint Server for Health Sciences|April 16, 2025
Integrating Pulmonary and Systemic Transcriptomic Profiles to Characterize Lung Injury after Pediatric Hematopoietic Stem Cell TransplantEmma M Pearce, Erica Evans, Madeline Y Mayday, et al.
Contemporary Clinical Trials|April 29, 2017
Developing standardized corticosteroid treatment for Duchenne muscular dystrophyMichela Guglieri, Kate Bushby, Michael P McDermott, et al.
Resuscitation|October 21, 2025
Neonatal Life Support: 2025 International Liaison Committee on Resuscitation Consensus on Science With Treatment RecommendationsHelen G Liley, Gary M Weiner, Myra H Wyckoff, et al.
Medrxiv : the Preprint Server for Health Sciences|December 11, 2023
Pulmonary microbiome and transcriptome signatures reveal distinct pathobiologic states associated with mortality in two cohorts of pediatric stem cell transplant patientsMatt S Zinter, Christopher C Dvorak, Madeline Y Mayday, et al.
Circulation|October 22, 2025
Neonatal Life Support: 2025 International Liaison Committee on Resuscitation Consensus on Science With Treatment RecommendationsHelen G Liley, Gary M Weiner, Myra H Wyckoff, et al.
Pediatrics|October 22, 2025
Neonatal Life Support: 2025 International Liaison Committee on Resuscitation Consensus on Science With Treatment RecommendationsHelen G Liley, Gary M Weiner, Myra H Wyckoff, et al.
Nature Medicine|May 23, 2024
Pathobiological signatures of dysbiotic lung injury in pediatric patients undergoing stem cell transplantationMatt S Zinter, Christopher C Dvorak, Madeline Y Mayday, et al.
Trials|May 26, 2018
A checklist for clinical trials in rare disease: obstacles and anticipatory actions-lessons learned from the FOR-DMD trialRebecca A Crow, Kimberly A Hart, Michael P McDermott, et al.
Pageof 186